Novel approaches to CNS diseases done by Cerevance
Longevity Technology - 03-Mar-2020After a successful phase 1 trial of the CVN424 done one mice, the company started phase 2 studies
Nathaniel Heintz
Professor of Molecular Biology at The Rockefeller University
Visit website: https://www.rockefeller.edu/our-scientists/heads-of-laboratories/1181-nathaniel-heintz/
See also: 
Rockefeller Neuroscience Institute
- Non-profit institution focused on the study of human memory and memory diseases
Details last updated 15-Mar-2020
Nathaniel Heintz News
